bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 14th, there was short interest totaling 4,070 shares, a growth of 415.8% from the July 30th total of 789 shares. Based on an average daily volume of 711 shares, the short-interest ratio is currently 5.7 days.
bioAffinity Technologies Stock Performance
Shares of NASDAQ:BIAFW opened at $0.13 on Wednesday. bioAffinity Technologies has a 52 week low of $0.05 and a 52 week high of $0.81. The company has a 50-day moving average price of $0.11 and a 200 day moving average price of $0.21.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Further Reading
- Five stocks we like better than bioAffinity Technologies
- Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
- 5 Stocks to Buy in September Before Wall Street Catches On
- PDD Beat Earnings—So Why Did the Stock Still Fall?
- Tariffs Are Back in Focus: 3 Stocks With a Home-Field Advantage
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
